Related Experiment Video
Updated: May 8, 2026
11:03
Robotic Left Hepatectomy using Indocyanine Green Fluorescence Imaging for an Intrahepatic Complex Biliary Cyst
Published on: June 24, 2022
5.5K
Upcoming multi-visceral robotic surgery systems: a SAGES review
Ankit Sarin1, Sarah Samreen2, Jennifer M Moffett2
1University of CA - Davis Health, 6th Floor, 2335 Stockton Blvd., Sacramento, CA, 95817, USA. axsarin@ucdavis.edu.
Surgical Endoscopy
|November 14, 2024
Summary
The robotic surgery landscape is rapidly expanding with new platforms nearing market entry. Increased competition from these novel systems is expected to drive innovation and potentially lower costs for patients undergoing minimally invasive surgery.
Area of Science:
- Minimally Invasive Surgery
- Surgical Technology
- Robotics in Medicine
Background:
- Robotic surgical procedures are experiencing significant global growth.
- Numerous novel robotic surgical platforms are in development or awaiting regulatory approval.
- This review focuses on platforms anticipated for US market release within 2-3 years.
Purpose of the Study:
- To identify and review emerging robotic surgical platforms.
- To assess systems nearing US Food and Drug Administration (FDA) approval.
- To provide an overview of key features and market potential.
Main Methods:
- The SAGES Robotic Platforms Working Group identified relevant platforms.
- Multi-visceral systems nearing FDA approval were selected.
- Key components, features, and regulatory status were documented.
Main Results:
- Twenty robotic platforms met the selection criteria.
- Ten platforms originated from North America, and ten from Europe or Asia.
- Detailed descriptions and comparative tables of system features were compiled.
Conclusions:
- Emerging robotic platforms signify a major advancement in minimally invasive surgery.
- Increased competition may foster innovation and reduce healthcare costs.
- While long-term impact is pending, the expansion of robotic surgery is highly probable.
